SOURCE: Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc.

June 03, 2009 08:00 ET

Sunwin International Increases Availability of Two Veterinary Medicines to Combat Swine Flu Virus in China

QUFU, CHINA--(Marketwire - June 3, 2009) - Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie Stevia in China, announced today that the company has increased the availability of two veterinary medicines, Huangqiduotang vaccine and Jinfang Detoxification Powder to treat swine flu that has recently spread in North America and other parts of the world. These products, currently used for controlling various types of influenza in China, have demonstrated effectiveness in controlling swine flu outbreaks among livestock.

Both veterinary medicines have been developed by authoritative veterinary experts within China. Jinfang Detoxification Powder is mixed in animal feeds, and Huangqiduotang vaccine is delivered via injection. Both products are antiviral, increasing the immunity of livestock to various types of flu viruses including swine flu. Sunwin is increasing its inventory of these products for distribution in China and potentially to other countries in the Far East if the virus spreads to these areas.

Laiwang Zhang, Chairman of Sunwin International, commented, "We believe that a quick response is essential to treating viruses like swine flu which can quickly cause pandemic concerns as it has in North America. Making these treatments more available in China ahead of potential threats is key to preventing widespread losses in livestock that could disrupt food supply chains at a substantial cost to the industry and the consumer. We are confident that broad availability of these products in China will help to control this type of virus threat and ease the minds of consumers troubled by this recent outbreak abroad."

Company Background:

Sunwin International Neutraceuticals, Inc. engages in the areas of essential traditional Chinese medicine, zero calorie natural sweeteners (Stevia), and veterinary medicines and feeds prepared from 100 percent organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. For more info about Sunwin, please visit http://www.sunwininternational.com.

Safe Harbor Statement

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our belief about the impact of Huangqiduotang vaccine and Jinfang Detoxification Powder will have in treating the swine flu virus, the potential loss of livestock and the potential disruption in food supplies.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2008 and our reports on Form 10-Q.

Contact Information